Survival advantage and clinicopathological significance of microRNA-22 in cancers: a meta-analysis

Qingming Xiang,1,* Zhenxian Xiang,2,* Rongzhang Dou,2 Bin Xiong2 1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors & Hubei Cancer Clinical Study Center, Wuhan 430071, People’s Republic of China;...

Full description

Bibliographic Details
Main Authors: Xiang Q, Xiang Z, Dou R, Xiong B
Format: Article
Language:English
Published: Dove Medical Press 2019-10-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/survival-advantage-and-clinicopathological-significance-of-microrna-22-peer-reviewed-article-CMAR

Similar Items